Drug Type Small molecule drug |
Synonyms 3,3,5-Trimethylcyclohexyl mandelate, 3,5,5-Trimethylcyclohexyl amygdalate, Cyclandelate (JAN/USP/INN) + [5] |
Target |
Action blockers |
Mechanism VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC17H24O3 |
InChIKeyWZHCOOQXZCIUNC-UHFFFAOYSA-N |
CAS Registry456-59-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00286 | Cyclandelate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cerebrovascular Disorders | - | - | - |
Peripheral Vascular Diseases | - | - | - |